 |
市场调查报告书
商品编码
1671893
全球威尔逊氏症治疗市场依治疗类型、给药途径、年龄层、通路及地区划分Wilson's Disease Treatment Market, By Type of Treatment, By Route of Administration, By Age Group, By Distribution Channel, By Geography |
||||||
2025 年全球威尔逊氏症治疗市场规模估计为 6.308 亿美元，预计到 2032 年将达到 9.932 亿美元，2025 年至 2032 年的复合年增长率为 6.7%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025 年市场规模 | 6.308亿美元 |
| 效能资料 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025-2032年复合年增长率： | 6.70% | 2032 年价值预测 | 9.932亿美元 |
威尔逊氏症是一种罕见的遗传疾病，会导致铜在肝臟和大脑等其他重要器官中积聚。它会影响身体透过胆汁和尿液释放铜的能力。如果不及时治疗，威尔逊氏症可能会导致严重的健康问题，甚至死亡。然而，透过正确的诊断和治疗，患者的预期寿命可以显着提高。随着全世界对该疾病的认识不断提高，越来越多的患者得到诊断并接受有效治疗。预计这将推动预测期内全球威尔逊氏症治疗市场的稳定成长。
市场动态：
由于疾病意识的提高和新诊断的增加，全球威尔逊氏症治疗市场预计将适度增长。新型治疗剂的开发也有望提供机会。然而，由于铜螯合剂是罕见疾病的治疗方法，其高成本可能会阻碍市场扩张。此外，开发中国家对该疾病的认知度低也也是一项挑战。然而，自愿组织和政府支持计画的倡议可能有助于解决负担能力问题并改善诊断，特别是在中低收入国家。
本研究的主要特点
本报告对全球威尔逊氏症治疗市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
全球威尔逊氏症治疗市场的主要企业是根据公司亮点、产品系列、关键亮点、绩效和策略等参数列出的。
研究中涉及的主要企业包括 Valeant Pharmaceuticals International、Merck &Co、Tsumura &Co、VHB Life Science Inc.、Teva Pharmaceuticals USA Inc.、Wilson's Therapeutics AB、Noble Pharma Co.Ltd.、Kadmon Holdings Inc.、Zydus Cadila、Sururolan NV、Sasam、Mimom、ASk、Amoions）
从本报告中获得的见解将使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球威尔逊氏症治疗市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员将透过用于分析全球威尔逊氏症治疗市场的各种策略矩阵更轻鬆地做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要进展
- 监管情景
- 产品发布/核准
- PEST分析
- 波特的分析
- 併购情景
- 产业趋势
4. 全球威尔逊氏症治疗市场按治疗类型划分（2020-2032 年）
- 药物治疗
- 肝臟移植
- 饮食管理
5. 全球威尔逊氏症治疗市场依给药途径划分（2020-2032 年）
- 口服
- 肠外
- 其他的
6. 全球威尔逊氏症治疗市场按年龄层划分（2020-2032 年）
- 孩子
- 成人
- 老年人
7. 全球威尔逊氏症治疗市场按通路划分（2020-2032 年）
- 院内药房
- 零售药局
- 网路药局
8. 全球威尔逊氏症治疗市场按地区划分（2020-2032 年）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第九章 竞争格局
- Valeant Pharmaceuticals International
- Merck & Co
- Tsumura & Co
- VHB Life Science Inc.
- Teva Pharmaceuticals USA Inc.
- Wilson's Therapeutics AB
- Noble Pharma Co. Ltd
- Kadmon Holdings Inc.
- Zydus Cadila
- Mylan NV
- Hikma Pharmaceuticals
- Sandoz（a Novartis division）
- Aurobindo Pharma
- Amgen Inc.
- Pfizer Inc.
第 10 章分析师建议
- 命运之轮
- 分析师观点
- Coherent Opportunity Map（COM）
第 11 章 参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
Wilson's Disease Treatment Market is estimated to be valued at US$ 630.8 Mn in 2025 and is expected to reach US$ 993.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | US$ 630.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.70% | 2032 Value Projection: | US$ 993.2 Mn |
Wilson's disease is a rare genetic disorder that causes copper to accumulate in the liver and other vital organs like the brain. It affects the ability of the body to release copper through bile and urine. Untreated Wilson's disease can cause serious medical problems and may become fatal. However, with proper diagnosis and treatment, life expectancy of patients can be improved significantly. As awareness about this condition is rising globally, more patients are being diagnosed and treated effectively. This is expected to drive steady growth in the global Wilson's disease treatment market during the forecast period.
Market Dynamics:
The global Wilson's disease treatment market is anticipated to witness moderate growth attributed to rising disease awareness and new diagnosis. Development of novel drugs for treatment is also expected to provide opportunities. However, high costs associated with copper-chelating agents, being orphan drugs, can hamper market expansion to some extent. Additionally, lack of disease awareness in developing nations poses a challenge. Nonetheless, initiatives by voluntary organizations as well as government support programs can help address affordability issues and improve diagnosis especially in low-and middle-income countries.
Key Features of the Study:
This report provides in-depth analysis of the global Wilson's disease treatment market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Wilson's disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Valeant Pharmaceuticals International, Merck & Co, Tsumura & Co, VHB Life Science Inc., Teva Pharmaceuticals USA Inc., Wilson's Therapeutics AB, Noble Pharma Co. Ltd, Kadmon Holdings Inc., Zydus Cadila, Mylan N.V., Hikma Pharmaceuticals, Sandoz (a Novartis division), Aurobindo Pharma, Amgen Inc., and Pfizer Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Wilson's disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Wilson's disease treatment market
Market Segmentation
- By Type of Treatment Insights (Revenue, USD Mn, 2020 - 2032)
- Pharmacological Treatment
- Chelation Therapy
- Zinc Therapy
- Liver Transplantation
- Dietary Management
- By Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
- Oral
- Parenteral
- Others
- By Age Group Insights (Revenue, USD Mn, 2020 - 2032)
- Pediatric
- Adult
- Geriatric
- By Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Valeant Pharmaceuticals International
- Merck & Co
- Tsumura & Co
- VHB Life Science Inc.
- Teva Pharmaceuticals USA Inc.
- Wilson's Therapeutics AB
- Noble Pharma Co. Ltd
- Kadmon Holdings Inc.
- Zydus Cadila
- Mylan N.V.
- Hikma Pharmaceuticals
- Sandoz (a Novartis division)
- Aurobindo Pharma
- Amgen Inc.
- Pfizer Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Wilson's Disease Treatment Market, By Type of Treatment
- Global Wilson's Disease Treatment Market, By Route of Administration
- Global Wilson's Disease Treatment Market, By Age Group
- Global Wilson's Disease Treatment Market, By Distribution Channel
- Global Wilson's Disease Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Wilson's Disease Treatment Market, By Type of Treatment, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmacological Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Liver Transplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Dietary Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Wilson's Disease Treatment Market, By Route of Administration, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Wilson's Disease Treatment Market, By Age Group, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Wilson's Disease Treatment Market, By Distribution Channel, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Wilson's Disease Treatment Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Valeant Pharmaceuticals International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tsumura & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- VHB Life Science Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceuticals USA Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Wilson's Therapeutics AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Noble Pharma Co. Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kadmon Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zydus Cadila
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hikma Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sandoz (a Novartis division)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aurobindo Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc.
- Pfizer Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
